Novavax NVAX announced that it has agreed to sell its manufacturing facility ... sale opportunities for the plant to save operating costs. If the deal with Novo Nordisk goes through, the company ...

The new plant will be one of the largest manufacturing investments in Novo Nordisk’s history and will add 1.4 million sq ft of production space for aseptic manufacturing and finished production ...

Novo Nordisk has started building its first brand-new manufacturing facility in Denmark since the millennium, saying it plans to spend around DKK 8.5 billion ($1.2 billion) on the plant.

While much of the recent GLP-1 saga has been written in the U.S., Novo Nordisk continues to expand ... into an expansion of its manufacturing plant in the Brazilian city of Montes Claros.

Pharmaceutical company Novo Nordisk will expand its production site in Montes Claros, Brazil, creating 600 jobs.

according to an April 25 news release from Novo Nordisk. The ruling allows the FDA to immediately take enforcement action against 503A pharmacies manufacturing “knockoff” versions of ...

Merck will grow its U.S. manufacturing footprint with a $1 billion plant, making it the latest drugmaker to invest in the U.S ...

Novo Nordisk (NYSE:NVO)) is going big in Brazil. The drugmaker behind Ozempic and Wegovy just dropped a $1.09 billion investment to supercharge its manufacturing plant in Montes Claros.

some uncertainty remains along with the risk of disruptions for Novo Nordisk as tariffs will increase prices. The company's key manufacturing facility is still in Denmark, though it does produce ...

Novo Nordisk announced it is partnering with telehealth platforms to offer its blockbuster drug Wegovy. The move will help it capture a large number of consumers who had flocked to digital health ...

Eli Lilly's manufacturing plant in Limerick. President Trump said he would shortly unveil tariffs on pharmaceutical imports. (Paulo Nunes dos Santos/Bloomberg News) Stocks in drugmakers sold off ...

Novo Nordisk has invested 6.4bn Brazilian reais ($1.09bn) to expand its facility in Brazil as the company ramps up efforts to increase production of its flagship glucagon-like peptide 1 receptor ...